BAY 1135626
Product Specifications
CAS Number
1404071-37-9
Target
Drug-Linker Conjugates for ADC
Related Pathways
Antibody-drug Conjugate/ADC Related
Bioactivity
BAY 1135626 synthesizes BAY 1129980, an Auristatin-based anti-C4.4A (LYPD3) antibody–drug conjugate (ADC) used in non–small cell lung cancer (NSCLC) research and anti-tumor studies [1].
Smiles
C([C@H](NC([C@@H]([C@@H](OC)[C@]1(N(C(C[C@H]([C@@H](N(C([C@@H](NC([C@@H](N(CCCC(NNC(CCCCCN2C(=O)C=CC2=O)=O)=O)C)[C@H](C)C)=O)C(C)C)=O)C)[C@H](CC)C)OC)=O)CCC1)[H])C)=O)C(N)=O)C=3C=4C(NC3)=CC=CC4
Molecular Formula
C55H86N10O11
Molecular Weight
1063.33
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
YP-W19473-01 48 Tests
Human transmembrane 4 superfamily 12 (TM4SF12) ELISA Kit
Sign In for Pricing
View Details